International sourcing has given employers a way to access certain high-cost medications from licensed pharmacies in countries where prices are significantly lower. Now, new customs requirements taking effect in January 2027 and a federal appeals court ruling are raising real questions about whether these programs can keep delivering.
In this on-demand webinar, Truveris Clinical Director Aya Desouki, PharmD, explains how international sourcing programs work, explores the fulfillment changes and legal developments putting pressure on them, and discusses what these shifts could mean for members who rely on these programs today.
Aya also covers the risks and advantages employers should weigh, from member disruption and clinical oversight to the gap between gross and net savings, and the questions plan sponsors should be asking their vendors right now.
Learning Objectives
- Understand how international sourcing programs work: Learn how these programs source medications from licensed pharmacies in tier one countries, which drugs they typically target, and how they differ from state-led drug importation.
- Evaluate the impact of 2027 customs changes and recent litigation: Explore how new customs requirements and court ruling could delay, disrupt, or end international fulfillment pathways.
- Assess member, clinical, and financial risks: Understand the potential for member disruption, gaps in care coordination and medication reconciliation.
- Prepare a contingency strategy for 2027: Learn how to support members who may need to transition to domestic pharmacy channels, and why ongoing oversight of these programs matters.
Watch: International Sourcing in Pharmacy Benefits
